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Summory
We tested ifferent ypes of clot for their ability to provoke procoa-
guiant activity in platelets: normal clots from platelet poor plasma (des
AABB- or fibrin II clots), similar clots in which the adsorbed thrombin
has been inhibited by hirudin, and clots obtained by the action of two
snake venom enzymes that release only fibrinopeptide A (des AA- or
fibrin I clots). Analogous ciots from fibrinogen solutions were also
tested.
In platelet rich plasma (PRP), where platelet coagulant phospho-
lipids (PCP) are rate limiting for thrombin generation, the addition of
any type of clot enhances the generation of thrombin thus it induces the
appearance of PCP. Clots containing active adsorbed thrombin are the
most potent ones in this respect. Lactate dehydrogenase (LDH) levels
do not increase in the course of the thrombin generation so the platelets
are not damaged in the process. Non-qentrifugable PCP could be de-
monstrated to appear during the process, so the production of pro-
coagulant phospholipid microparticles must be part of the mechanism.
Membrane transbilayer phosphatidyl serine movement (flip-flop) can
not be demonstrated in PRP as the activated platelets are caught in the
emerging clot.
In order to demonsffate flip-flop, we tried to investigate the influ-
ence of clots on washed platelets. However, contrary to platelets in a
plasma milieu, isolated platelets are damaged by fibrin clots, especially
in the presence of thrombin, as can be judged from the appearance of
LDH.
We conclude that, in PRP, clots induce the appearance of PCP from
platelets by vesicuiation, possibly accompanied by flip-flop and that
thrombin accelerates the process but is not an absolute requirement.
Inlroduclion
It is becoming increasingly evident that primary haemostasis
through platelet activation and aggregation ald secondary haemostasis
through clotting are processes that amplify each other in all types of
haemostatic and thrombotic events (see ref. 1 for a review). A powerful
resonance loop establishes itself at a site of vessel injury because
thrombin very effectively activates platelets and aciivated platelets
accelerate hrombin generation by exposing a procoagulant phospho-
lipid surface (2-4) and releasing platelet factor V (5-7). Thus, the for-
mation of thrombin and platelet activation are interdependent processes
and it is not easy to dissociate the role of one from another.
Conespondence to:Dr. S. B6guin, Faculty of Medicine and Cardiovascular
Research Institute, Department of Biochemistry, University of Limburg,
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In the process of clotting of fibrinogen by thrombin, a certain
amount of thrombin is adsorbed on the fibrin (8-11). Clotbound throm-
bin still exhibits catalytic activity since it has been reported to catalyze
the release of FPA frorn fibrinogen (12-14), to hydrolyse chromogenic
substrates (13) and to shofien the coagulation time ofblood and plasma
(14-16). The fibrin clot thus behaves as a reservoir of enzymatically-
active thrombin, more significantly so as the inhibition characteristics
of bound thrombin by plasma ntitltombins have been demonstrated to
be much different from fluid phase thrombin, notably that this thrombin
is insensitive to antithrombin (11,12,15). There also arises the ques-
tion, whether the adsorbed thrombin still could function in the throm-
bin-mediated feedback reactions that are so typical for the coagulation
mechanism. Recently we have reported (17, 18) that clot-bound
thrombin could indeed further enhance thrombin formation by
sustaining the activation of plasma cofactor proteins factor V and VIII.
We have also observed that in platelet rich plasma (PRP) clofs signi-
ficantly lower the lag phase prior to the burst of thrombin generation,
indicating that platelets are activated by clots.
The present article investigates the influence of clots produced by
thrombin and non{hrombin enzymes on the stimulation of platelets. It
has been shown that the major platelet surface receptor GPIIb/IIIa
(o,,0B., integrin) is activated by a variety of extracellular matrices in-
cluding fibrin (l 9) leading to highly adherent behaviour of the platelets.
Clots may also induce the platelet release reaction (14). Because
there are several forms of platelet activation that do not lead to the ex-
posure ofprocoagulant surfaces (20), it remains to be seen how the pro-
coagulant behaviour of the platelets is affected by clots and clot bound
thrombin. To this end, in the work presented here, we have studied the
effect of different ypes of clots on the generation of platelet prothrom-
bin converting activity in platelet rich plasma and in suspensions of
washed platelets and compared it with the effect of well known platelet
activators uch as Ca2*-ionophore A23181 or IIa and collagen, alone or
in combination.
Moleriols ond Mefhods
Materials
Fatty acid free bovine serum albumin (BSA), ovalbumin (grade V) and Cal-
cium ionophore, A23187 were purchased from Sigma (St Louis, MO). Horse
tendon collagen (type I) was from Hormon Chemie (Munich, Germany). Chro-
mogenic substrate used for thrombin was 52238: H-D-Phe-Pip-Arg-
pNA.2HC1 Purified fibrinogen was obtained from Kordia (Leiden, The Nether-
lands) Reptilase was supplied by Laboratories Stago (Asnidres, France) and
Agihal, a purified fraction of Agkistrodon halys halys snake venom, that splits
fibrinopeptide A from fibrinogen was obtained from Prof. L. Yukelson
(Tashkent, Uzbekistan). Recombinant hirudin (Knoll AG) was a kind gift of
Dr. W. Homberser.
Plasma
PRP for thrombin generation experiments was obtained by centrifugation
at250 g,15" C, 10 min of freShly drawn citrated blood (1 volume trisodium
citrate 0.13 M to 9 volumes blood) of a healthy donor. The platelet count was
adjusted to 3+108/ml with homologous platelet poor plasma (PPP) obtained by
double centrifugation of PRP at 1000 g, 15" C, 10 min.
PRP for the measurement of generation ofplatelet procoagulant activity was
obtained from blood taken 5:1 on ACD (183 mM glucose, 80 mM trisodium
citrate, 52 mM Citric acid) centrifuged under the same conditions as described
above The platelet count in this case was adjusted to 1 * 10Vml
Platelet Preparations
Six volumes of blood drawn from healthy donors by venipuncture was
collected on one volume of an anticoagulant mixture consisting of 42 mM
EDTA,42 mM trisodium citraIe,25 mM NaOH (pH 6.6). The blood was cen-
trifuged for 15 min at 250 g The platelet rich supematant thus obtained was
subsequently centrifuged for 5 minutes at 160 g to remove any remaining
erythrocytes and leukocytes. The PRP was further centrifuged for 15 min at
500 g and the platelet pellet was resuspended in 19 volumes buffer (pH 6.6)
consisting of 25 mM HEPES, 136 mM NaCl, 2.68 mM KCl, 1.7 mM MgClr,
25 mM glucose, 0 5% BSA and I volume anticoagulant mixture (see above).
Platelets were thus washed twice centrifuging at 500 g for 15 min and were
finally resuspended in I volume Hepes buffer (pH 6.6) and 4 volumes of same
Hepes buffer (pH 7 5). The platelet concenfrations were determined using a
Coulter counter. All the platelet handling was done at room temperature.
Proteins
Human prothrombin was purified according to Discipio et al. (21) Throm-
bin was purified from protkombin after activation with factor Xa as described
by Rosing et al. (22) The thrombin concenftation was determined by active
site titration according to Chase and Shaw (23). Rovine factor Xa was prepared
from factor X, using RW-X according to method of Fujikawa et al (24).Fac-
tor Xa concentrations were calculated after active site titration according to
Smith (25). Bovine factor V was purified by rhe procedure descnbed by Diihl-
back (26) and Suzuki et aL. (27) with minor modificarions as explained in ref.
28 Factor Va was prepared by activation offactor V wlth thrombin and con-
centrations of Va were determined kinetically as described by Lindhout et a1.
Q9)
Methods
Preparation of Clots
Plasma clots: PPP (250 pl for one clot) was coagulated by recalcification to
a final concentration of23 mM CaCl, in a glass tube and incubated at 37. C for
1/, h. The clot was wound on a plastic spatula, dried and incubated in (human)
serum for 10 min. The clot was then extensively washed in 2 ml of Buffer A that
was changed three times in order to eliminate any soluble material trapped in
the clot. That no unbound thrombin rematned with the clot was checked by the
absence of amidolytic activity in the last washing buffer on 52238.
Purified fibrinogen clots were prepared from 250 pl of 3 mg/ml fibrinogen
solution in 150 mM NaCl, by adding CaClr(23 mM) and 1/50 volume of Rep-
tilase or Agihal solution or, in some cases, 30 nM IIa. Extensive washing of the
clots was practised in all the cases. Non-crosslinked fibrin clots i. e. des AA
fibrin obtained by the action of snake venoms that only release fibrinopeptide A
have been refened to as fibrin I clots while des AABB fibrin clots (cross linked)
are designated as fibrin II clots.
Measurement of Thrombin Generation i  PRP
This was done as previously described (30). Briefly, 240 pl of pRp was
diluted with 60 pl of Buffer A (50 mM Tris HCl, 100 mM NaCl, 0 5% BSA:
pH 7.35) and coagulation was triggered with 60 pl CaCl, (Final concenrrarion
16 7 mM). The clots were added to the reaction mixture 90 s after triggering
coagulation The reaction mixture was continuously stined by a small spatula
and 10 pl subsamples were drawn at equally spaced intervals and diluted in
prewarmed (37" C) cuvettes containing 490 pl of Buffer B (Buffer A with
20 mM EDTA, pH 7.9) containing 200 pM 52238. The reacrion was stopped
after 2 min by adding 300 pl of 1 M Citric acid. As soon as the reaction mixture
coagulated, the clot was wound on the spatula nd discarded. From the rate of
change of optical density measured at 405 nm, the amidolytic activity was cal-
culated by comparing with a standard calibration curve made wth active
site - titrated human o{hrombin
Measurement ofPlatelet Prothrombin Converting Activitl
In washed platelet suspensions: The reaction mixture consisted of 343 p,1 of
washed platelet suspension with platelet count 0.5*108/ml to which 7 pl of
100 mM CaCl, was added. The mixture was magnetically stined at 31" C at
350 rev/min with teflon coated stining bars. A stining assembly was used
which allowed to stir 7 reaction mixtures imultaneously at"3'7" C. After 3 min
prewarming, platelet activation was initiated by adding a platelet stimulator
The generation of platelet prothrombin-converling activity was determined by
transferring a 10 pl sample from the platelet activation mixture to 240 pl of an
assay mixture containing 3nM factor Va, 5 nM factor Xa and 1 pM prothrom-
bin in 25 mM Hepes (pH7.7), 175 mM NaCl, 5 mg BSA/n1, 2 mM CaClr.
A reference prothrombinase blank was measured by transferring a 10 pl
Hepes buffer pH 6.6 aliquot o the prothrombinase mixture instead of the plate-
let activation mixture.
The formation of thrombin was stopped after 1 min by transfening 10 pl
aliquots to cuvettes (at 37" C) with 990 pl buffer (50 mM Tris, 175 mM NaCl,
0 5 mg/ml ovalbumin, 20 mM EDTA; pH 7 9) containing 335 pM 52238. From
the absorbancy change recorded at 405 nm, the amount of thrombin formed is
calculated via a calibration curve made with known amounts of thrombin The
time course ofgeneration ofplatelet prothrombin - converting activity was then
determined by samples taken from the platelet activation mixture at various
time intervals Controls with non-stimulated platelets were always run in paral-
lel Finally, the amount of thrombin formed in the prothrombinase blank was
subtracted from all the readings
In PRP: 100 pl of PRP, 1:6.7 diluted in Tris buffer A (see above) was in-
cubated for 5 min with or without clots. 50 pl subsample from PRP was
then transfened to 100 pl of an assay mixture containing 0.45 nM factor Xa,
10.5 nM factor Va, 3 pM Prothrombin and 12 mM Ca2* in Tris buffer A At
4 min, 10 pl of subsample was taken to the cuvette containing 465 pl ofTris
buffer B (see above). The amount of thrombin formed was calculated from the
absorbance hange measurement at 405 nm after the addition of 25 u,l of 52238(4 mM).
Release of Platelet Lactate Dehydrogenase (LDH)
Samples were assayed for the release of platelet LDH by using a commer-
cially available kit (Boehringer, Mannheim) 200 pl PRP or the aitivated plate-
let suspension was centrifuged at 9000 g for 3 min in an Eppendorf centrrfuge.
5 pl of the supematant was added to a cuvette with 125 pl of a buffer contai,
ning 51 7 mM Phosphate buffer (pH 7 .5),0.19 mM NADH and 0.6 mM Pyru-
vate. The activity of LDH was caiculated from the absorbancy change at
334 nm. The total LDH content of the platelets was determined in a platelet sus-
pension that was sonicated for I min.
Resulls
The Influence of Clox on Thrombin Generation i  PRP
In recalcified PRP, there is a prolonged lag phase prior to the throm-
bin burst. Lag times preceding thrombin generation i a plasma milieu
have been shown to be caused by the time required for a) factor V
and/or VIII activation and b) for the generation of a platelet procoagu-
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Since Agihal and reptilase-clots (fibrin I clots) have been shown to be
unable to promote factor V or VIII activation (18), this confirms the
rate limiting role of platelet procoagulant phospholipids. This strongly
suggests a direct effect of fibrin on the generation of platelet procoagu-
lant activity. To test this hypothesis, we have studied the influence of
fibrin clots on the generation of platelet procoagulant activity under
conditions where no thronbin could be formed, i. e. in suspensions of
washed platelets.
The EJfect of Plasma Clots on the Prothrombin-converting Activity
of Washed Platelets
Plasma clots were added to a washed platelet suspension and after
different ime intervals aliquots were drawn and transfered to assay
mixtures containing prothrombin, factor Xa, factor Va and Ca2*ions, in
which procoagulant lipid was the rate limiting component of prothrom-
binase. In this way the time course of generation of procoagulant
activity (i. e. prothrombinase activity) in the platelet suspension was
followed. The ability of clots to induce platelet procoagulant activity
was compared with that of the established platelet activators, thrombin
and the ionophore A23187 (Fig. 2). The incubation of platelets with
clots results in an immediate appearance of procoagulant activity that
linearly increases in time and that is proportional with the number of
clots present in the platelet suspension. Platelets incubated with one
plasma clot exhibit a 3-fold higher prothrombin-converting activity
than control platelets. Activation of platelets with 30 nM thrombin cau-
ses approximately the same effect as one clot. The stimulation by 3
plasma clots results in a linear increase that within one hour attains the
level of 60Va of the maximum procoagulant activitiy reached in platelet
suspensions activated with the Ca-ionophore A23187. The initial rate
of generation of procoagulant activity by the ionophore is, however,
much higher than that obtained in the presence of clots.
The prothrombin-converting activities induced by plasma clots and
other agonists (IIa, collagen, IIa plus collagen and A23187) are sum-
marized in Table l.
Under the conditions chosen in this experiment the capacity of the
various activators t0 induce platelet procoagulant activity is in the or-
der: A23187 >3 clots >IIa plus collagen >collagen >2 clots >1 clot
>IIa >no activator.
To check whether the generation of platelet procoagulant activity
should be attributed t0 the c10t itself or to a factor released from clots
the control experiments presented in Table 2 were performed. Clots in-
cubated with buffer in the absence of platelets do not induce any pro-
thrombinase activity. This means that clots do not release afactor that
on itself stimulates prothrombin activation. The supernatant of clots in-
cubated in buffer was unable to generate prothrombin-converting ac-
tivity in platelet suspensions. This excluded the possibility that some
platelet-activating substance extrudes from the clots and shows that
physical interaction between clots and platelets is a prerequisite for the
generation of clot-induced procoagulant activity in platelet suspen-
s10ns.
Another essential feature of clot-induced platelet procoagulant
activity is the requirement for stining during the incubation of platelets
with the clot. A similar requirement has been reported for the genera-
tion of platelet prothrombin-converting activity by thrombin, collagen
and A23187 (4, 31).
In our earlier work ( 1 8) it has been attempted to quantify the amount
of thrombin adsorbed to the clot by the technique of comparing the
thrombin potential, the area under the thrombin time curve in the pre-
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Flg. 1 The effect of fibrin clots on thrombin generation i PRP. Thrombin ge-
neration was triggered in PRP (platelet count 3* I 0E/m1) by the addition of Ca2+
(16.7 mM). The clots were added at t = 90 s. The amidolytic activity was deter-
mined in subsamples taken at 10 s intervals from which the thrombin activity
was calculated (30). (n) Control without clots, (l) 3 Clots obtained by recal-
cifying plasma were added (A) 3 Clots obtained from punfied fibrinogen by
adding Agihal (Fibrin I clots) were added
r
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Flg. 2 Time course ofplatelet prothrombin converting activity in washed pla-
telet suspensions. The stimulators were added to the platelet suspension (plate-
let count 0.5* 108iml) in the presence of 2 mM Ca2*. Protluombin activation was
measured atI pM Prothrombin, 5 nM Xa, 3 nM Va as described indetail in ma-
terials and methods The vanous platelet activators hown are (!) 4 pM
A23I8T, (I) 3 plasma clots, (t)) 2 plasma clots, (A) I plasma clot, (O) 28 nM
IIa. The control platelets (O) where without any stimulator. Representative ex-
periment of six so performed
lant surface under influence of traces of thrombin formed. We have
shown previously that in PRP, under the conditions used here, the
appearance of procoagulant phospholipids on/from the platelets is rate
liniting for thrombin generation (30). The presence of plasma clots
considerably shortens the lag time that precedes the thrombin burst in
PRP (Fig. 1). Surprisingly, this effect is not critically dependent upon
the presence of thrombin, clots generated by thrombin-like venom en-
zymes such as reptilase and Agihal, also shorten the lag phase in PRP.
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Thrombin
Collagen
Thromb + Coll
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3 clots
L23r87
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34-95
62 165
I  l8-158
47 -101
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84-450
394-s36
2 3 t  5 ( n = 1 3 )
66 x2I (n= 6)
99x46 (n=31
l l R + ) 0 t n - l t
' 72x20 (n=6 )
9 1 t 3 8 ( n = 6 )
286 t 68 (n = 13)
414 xlj (n= 12)
The amount of IIa formed (nM) after 60 min of platelet activation in the ab-
sence or presence of various stimulators The results are represented as
Avg t SD (number of times the experiment rs done) To express, the donor
dependent scatter the range obtarned is also given. Experimental conditions are
the same as in legend of Fig. 2. The concentrations of stimulants were: IIa
(30 nM), Collagen (10 pg/ml), Ila/collagen (1 nM IIai1O pgiml collagen),
423187 (4 pM). Fibrin II clots have been used
Table 2 ReErirements for the generation ofprothrombin-converring activity
in plateletclot suspensions
Experiment Reaction mixture Protluombin-
convertlng actlvlty
(nM Ila/min)
Table I Platelet procoagulant activity provoked by different triggers in
washed platelet susnensions
Trigger Leve la t t=60 Range
obtaining the clots) and prothrombinase activity was measured (Inset
graph, Fig. 3). With fibrin I clots, a modest but significant increase of
the prothrombin-converting activity was seen, that was, h0wever much
lower than that of fibrin II clots. This is indicative for a role of both
fibrin (I or II) and clot-bound thrombin in the generation 0f procoagu-
lant activity in washed platelet suspensions.
The importance of clorbound thrombin was fufiher tested by deter-
mining the effect of plasma clots that were treated with an inhibitor of
thrombin. To this end plasma clots (fibrin II clots) were incubated with
1 pM of hirudin for about 2 h, blotted dry and transfened to the plate-
iet suspension without washing. In this way a small fraction of the hiru-
din is transfened to the platelet activation mixture, in order [0 ensure
complete inhibition of thrombin bound to the clot. Since in our pro-
thrombinase assay the platelet suspension is subsampled to a mixture
with prothrombinase components, the hirudin that is canied over is
diluted many times. We determined that the amount of hirudin canied
over was less than I nM in the final solution which will be too low to
inhibit the thrombin formed in the assay mixture. However, to confirm
this a control experiment was performed in which 30 nM hirudin was
added to the platelet mix containing three plasma clots. The time
course of generation of platelet prothrombin converting activity was
determined by drawing aliquots from the mixture and ffansfeffing
them to the prothrombinase mix. By dilution just over 1 nM hirudin
reaches the final solution in this way. The amount of thrombin meas-
ured after 60 min of platelet activation was 326 nM which is above the
mean of 13 experiments without hirudin and within the mean + 1 SD
range (Table i).
Clot associated thrombin activity before and after hirudin treatment
was determined by measuring the amidolytic activity on 52238. With
three untreated fibrin II clots the thrombin measured after 15 min of in-
I
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Buffer
Supernatant of clot suspension
Platelets
Platelets + supematant of 3 clots
Platelets + 3 clots
5 t 1
6 x 2
8 t 1
8 t 3
286 t 68
Experimental set up was the same as for Fig. 2 In experiments 1 and 3 the
reaction mixture consisted of Hepes buffer (pH 6.6. see matenals and methods)
and platelet suspension respectively In experiment 2. he plasma clots were in-
cubated inbuffer in the absence of platelets, For experiment 4, he plasma clots
were incubated in buffer for 30 minutes The clots were taken out and platelet
suspension was added Finally in experiment 5. the prothrombinase ctivity was
measured when plasma clots were incubated with platelet suspension. In all the
experiments 2 mM Ca2* was added. The results are expressed asAverage + SD
(n = 5 for first 4 experiments and n = 13 for experiment 5).
sence and absence of fibrinogen. The thrombin potential was found t0
be 31 x 37a (mean + SEM, n = 10) lower in the presence than in the ab-
sence of fibrinogen with similar amounts of prothrombin being con-
verted. This indicates that about 3070 of aII the thrombin formed is ad-
sorbed 0n to fibrin. Indeed it was also seen that the peak ievel of free
thrombin decreases from about 110 nM to about 80 nM.
Effect of Clots that do not Contain Thrombin
The experiments reported above were performed with clots that are
known to contain bound thrombin (i. e. uninhibited fibrin II clots). The
experiments in Fig. I show that clots obtailed by the acion of snake
venom enzymes on purified fibrinogen (fibrin I clots) are also able to
generate platelet procoagulant activity Figure 3 shows a time course of
generation ofprothrombin-converting activity in platelet suspensions in
which fibrin I clots were used as platelet agonists. To ensure that
venoms by themselves do not influence the reaction, Agihal and Rep-
tilase were added to the platelet activation mixture in 1/ro volume (as for
'./t
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Fig. 3 Effect of addition of Fibrin I clots on platelet prothrombin converting
activity in washed platelet suspensions. Experimental set up is the same as in
legend of Fig. 2. The clots generated from purified fibrinogen by adding (A)
Agihal and (l) Reptilase (Fibrin I clots not containing any thrombin) were used
as platelet stimulators. The control platelets (O) were without any stimulator 3
clots have been used The graph represents average values for 6 donors. The in-
set graph represents he control experiment with Agihal (A) and Reptilase (!)
added to the platelet activation mixture in 1/50 volume
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Fig 4 Effect of addition of IIa to fibnn I clots and hirudin treated clots.
Washed platelet suspension was activated by (!) Fibrin I clots and (A) plasma
clots with inhibited IIa (treated with I pM Hirudin) for 60 minutes, after which
5 nM IIa was added to the platelet activation mixture. The control platelets (O)
were without stimulalor till 60 minutes and then 5 nM IIa was added to them.
The platelet procoagulant activity was measured as described in the legend of
Fig. 2. The solid symbols represent the contrnuations of the same curves after
thrombin addition
even exceed those obtained with the Ca-ionophore 423181 . Such a rise
does not occur when thrombin is added to control platelets incubated
without c10ts. In these experiments the levels of prothrombin-con-
verting activitiy are much higher than those obtained with unfeated
plasma clots. This indicates that the synergistic effect offree thrombin
in the generation of fibrin-induced platelet procoagulant activity is
much more pronounced than that of clotbound thrombin.
Leakage of Lactate Dehydrogenase
Platelet procoagulant activity can result ftom a transbilayer transport
of phosphatidylserine to the outside 0f the intact membrane (fiip-flop),
by the shedding of microparticles or by disruption of the ce1l mem-
brane. As a measure of membrane disruption we used the release of
cytoplasmic lactate dehydrogenase. To estimate the contribution of
membrane damage to the generation of procoagulant activity we plot-
ted the latter as a function ofthe release ofLDH (Fig. 5). It is seen that
the combination of thrombin with clots (of any type) causes proco-
agulant activity that is accompanied by substantial release of LDH, as
is, a fortiori, the activity produced by sonication. Thrombin plus colla-
gen, or the Ca-ionophore cause a release of LDH that, for the same
amount of procoagulant activity, is only 207o of maximal. So the plate-
let procoagulant activity induced by clots in washed platelets is lysis
associated.
This inposed LDH measurements in PRP during thrombin genera-
tion. The LDH level measured in PPP was 102Ull. in sonicated PRP
the level was 594 U/ml. However in PRP, not significant rise in LDH
was obtained (Fig. 6). Knowing the experimental variation of the indi-
vidual measurements, this means that less than l% of the platelets had
shed its LDH during the clotting of PRP.
.1
cubation was 14.8 nM while after hirudin treatment (1 pM) the value
dropped to 1.28 nM. This residual activity is probably thrombin in-
dependent splitting of 52238 because the value observed for fibrin I
clots produced without contact with thrombin was I . 15 nM.
Table 3 shows that thrombin-containing clots have a significantly
higher activity than clots that do not contain thrombin but that the latter
anvhow also exhibit activitv
Table 3 Comparison of activities evoked by various clots in washed platelet
suspenslons
Agonrst 7o Procoagulant activity
(after 60 min of platelet activation)
Plasma clots 100 t 9 8
Fibnnogen + IIa (30 nM) clots 98 t 10.2
Plasma clots treated Hirudin (1 pM) 26 x 4.6
Fibrin I clots 21 x4.8
N o n e  8 1 1 1
Experimental set up is the same as for Fig. 2. The various clots were obtained
as described under methods. For the purpose of comparison the prothrombinase
activity induced by plasma clots has been taken as l00vo value The data bb-
tained for 9 donors is expressed as Average + SEM
966
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The Effect of Thrombin on the Prothrombin-converting Activiry p aoo
ol Plateler-clot Suspensions E ..
Washed platelets were incubated tbr 60 min in the presence ofclots E *.
that did not contain active thrombin (fibrin I clots or hirudin{reated ! ..
piasma clots) prior to the addition of 5 nM thrombin. Figure 4 shows $,
that the addition of thrombin to platelet suspensions that contain clots e 200
causes the platelet procoagulant activity to rise steeply to levels that 100
60
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Flg 5 Prothrombinase activity with conesponding Platelet Lactate Dehydro-
genase (LDH, U/l) obtained after 60 min of platelet activation in washed plate-
let suspension. Prothrombinase activity was measured as described in the Ie-
gend of Fig. 2. For the measurement of release of platelet lactate dehydrogen-
ase, 200 pl of activated platelet suspension was centrifuged at 9000 g for 3 min
Supematant was added to a cuvette containing Phosphate buffer (51.7 mM, pH
7.5), NADH (0.19 mM), Pyruvate (0.6 mM). The activity of LDH was calculaf
ed from the absorbency change at 334 nm. The total LDH content of platelet
suspension was determined in a sonicated sample (x) The other points repre-
sent he values obtained when the agonist were: (A) Fibdn I clots; (+) Fibrin I
clots with 5 nM thrombin added to the platelet activation mixture after
60 min of platelet activation; (O) Plasma clots; (O) Plasma clots treated
with hirudin; (O) Thrombin/collagen (1 nM thrombin/1O pg/ml collagen); (A)
Ca2* ionophore and (l) none
o 2 0 &
EE
o
F
o
a
G
o
o
o
F
a
G
J
o  6  1 2  1 8
Time(min)
Flg. 6 Measurement of LDH in PRP simultaneously with tlrombin genera-
tion. Thrombin generation was triggered in PRP by addition of Caz* (16 7 mM).
(!) Control without clots. (l) Plasma clots added. PRP samples were drawn
from both the parallel experiments at various time intervals and analyzed for
the release of LDH (shown on left Y axis) as described in legends of Fig 5 The
horizontal line represents he base LDH obtained in PPP i. e. 102 U/l and the
points about it give the LDH values measured for the two series in the same
symbols The LDH value obtained for sonicated PRP was 594 U/l
Table 4 Generation ofplatelet procoagulant activity in platelet rich plasma on
addition of clots
Reaction Mixture Prothrombin Converting Activity
(nM Ila/min)
PRP
PRP+3plasmaclots
PRP + 3 clots from purified fibrinogen
PPP
4 3  x 9
1.51 t34
'72 t 15
2 I  x 6
For the measurement of platelet procoagulant activity, 100 pl of PRP
(1 * 108/m1) was diluted 1:6 7 in Tris buffer A (see materials) and incubated with
or without clots for 5 minutes. 50 pl subsample was transfened to 100 pl of
prothrombinase mixture containing Xa (0.45 nM), Va (10.5 nM), Prothrombin
(3 U.M), Ca2* (12 mM). At 4 min, the reaction was stopped by taking 10 pt sub-
sample to cuvette with 465 pl Tris buffer B (with EDTA). The amount of
thrombin formed was calculated from the absorbance change at 405 nm after
adding 4mM 52238. The results are expressed as Average t SD for 5 experi-
ments.
Platelet Procoagulant Activity Generated in PRP
in the Presence of Clots
In order to confirm the action of clots on the disclosure of procoag-
ulant phospholipids by clots, both fibrin I and fibrin II clots were added
to PRP and the generation of platelet procoagulant activity was fol-
lowed in subsamples that were transferred toa prothrombinase mixture
devoid of phospholipids, as used for washed platelets. Table 4 lists the
values obtained after 4 min of activation. Measurements simultaneous-
ly carried for PPP incubated with clots and PRP without clots served as
cOntrols.
Discussion
We previously reported that thrombin bound to fibrin is capable to
activate factors V and VIII (18). In the course of these experiments it
appeared that fibrin clots, even if they did not contain thrombin, foster
thrombin generation i  platelet rich plasma (PRP). In this article was
further investigate the mechanism behind this phenomenon.
Platelets can assist in thrombin generation by exposing procoagulant
phospholipid and by releasing factor V. Under our experimental condi-
tions, i. e. in 2:3 diluted normal PRP, factor V is present in excess and
procoagulant lipids are rate limiting (30). Therefore the release of
factor V does not contribute significantly to the thrombin generating
capacity of PRP but the availability of procoagulant phospholipid from
platelets does. So, if fibrin clots enhance thrombin generation i PRP,
these clots must induce the exposure of such phospholipids.
Platelet procoagulant phospholipid activity, also called platelet fac-
tor 3 (PF3), is dependent upon the exposure of negatively charged phos-
pholipids, chiefly phosphatidylserine (PS). In the resting platelet, PS is
almost exclusively located in the cytoplasmic layer of the cell mem-
brane. Upon activation by thrombin or collagen, and especially if both
activators are present, PS is transfened from the inner to the outer
monolayer of the intact membrane (3). In this process platelets also
shed procoagulant phospholipid particles (32,33). PS also gets exposed
when the platelet membrane is disrupted by methods uch as freeze
thawing or sonication. Such extreme situations however do not occur in
vivo and their biological significance seems limited.
Our results show that fibrin clots of any type provoke platelet pro-
coagulant activity in PRP as well as in washed platelet suspensions.
Notably non cross-linked fibdn I clots, obtained with snake venom en-
zymes that only release fibrinopeptide A, still exhibit abtivity. In isolat-
ed platelets the presence of thrombin is necessary for a maximal effect
(Table 3). This may be thrombin already adsorbed to the clot. In plas-
ma, where explosive thrombin generation ecessarily follows the
appearance of platelet procoagulant activity, it is hard to distinguish
between the effect of fibrin alone and that of fibrin plus thrombin.
Contrary to what could be expected from its effect on the isolated
platelets (3), collagen has been reported not to enhance thrombin gen-
eration in PRP (30). The obvious difference between the two situations
is that in PRP fibrin is formed by the thrombin generated. We therefore
wanted to explore the possibility that fibrin mrght replace collagen as
an inductor of the flip-flop reaction. However, when isolated platelets
are stimed with clots, especially if thrombin is present too, they disrupt,
as can bejudged from their shedding LDH (Fig. 5). This experimental
setup therefore is not suitable for the demonstration f flip-flop, and the
experiments are inconclusive. In contrast, he induction by clots ofpro-
coagulant activity in platelets in PRP is nof accompanied by the
shedding of LDH. This means that the procoagulant activity is due to
PS at the outside of non-disrupted platelets and/or of shedded micro-
particles. We suppose that the isolation of piatelets renders them more
vulnerable than platelets in PRP are. We are searching for conditions in
which isolated platelets can be incubated with fibrin and thrombin with-
out shedding LDH but thus far we did not find any. For the moment we
have no data that make us revise our original hypothesis that fibrin in
clotting plasma can play a similar role as collagen does in suspensions
of isolated platelets.
Our'observations broach the question of in how far platelet disrup-
tion may be an integral part of the physiological haemostatic reaction.
It is not uncommon for cell death to contribute to physiological
functions (cf. holocrine secretion) (34) and disrupted platelets are a
common phenomenon i  EM pictures of the haemostatic plug (35).
In Table I we observe a large variation in platelet procoagulant
activity. This is only partly due to random experimental error. In fact
the experimental variation when calculated from experiments canied
out on the same platelet suspension under identical conditions was less
thanSTa. The remainder of the variation must be ascribed to variation of
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the platelet reactivity between donors. This suggest that platelet excif
ability may vary considerably between subjects. It would be interesting
to do epidemiological studies on platelet reactivity in relation to age,
illness and cardiovascular risk.
In conclusion: We have demonstrated that fibrin, both type I and
type II, does provoke procoagulant activity in platelets. Thrombin sig-
nificantly potentiates this phenomenon. When they are in their natural
milieu this is not accompanied byplatelet breakdown, but isolated pla-
telets are damaged uring these experiments. There is a considerable
variation in reactivity between donors that remains to be explored.
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